Search

everythinglearnresearchcommunity

for

Search:↓

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Finasteride may lower cholesterol and slow heart disease progression.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Photobiomodulation improves the quality of life for people with hair loss.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Female-pattern baldness is not linked to more migraines.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Gene mutations can cause problems in male genital development.